Recommended

Pharma
Pharma December 11, 2024

STAT Plus: Eli Lilly strikes Zepbound deal with Ro, amid questions about future of compounded GLP-1s

By Elaine Chen and Katie Palmer

Biotech
Biotech December 11, 2024

STAT Plus: Gene-editing field sees another merger, this time between Chroma Medicine and Nvelop Therapeutics

By Jason Mast

advertisement

Biotech
Biotech December 10, 2024

An entertaining biotech fight, and a ‘nail in the coffin’ for transplants in mantle cell lymphoma

By STAT Staff, Adam Feuerstein, Angus Chen, and Meghana Keshavan

Biotech
Biotech December 10, 2024

STAT Plus: Eli Lilly to test obesity medications as treatments for alcohol and drug addiction, CEO says

By Elaine Chen

D.C. Diagnosis
D.C. Diagnosis December 10, 2024

STAT Plus: Budget negotiations heat up as ACA subsidy extension, BIOSECURE get dropped

Subscriber Picks